Clinical trial
Spermidine Anti-Hypertension Study
NCT04405388 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spermidine Anti-Hypertension Study
- Lead sponsor
- Medical University of Graz
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 25, 2020
- Completion date
- November 15, 2024
- Enrollment
- 46 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.